文献速递精神分裂症与精神病性障碍

两个月认知变化可增强对临床高危个体未缓解的预测

Two-Month Cognitive Changes Enhance Prediction of Nonremission in Clinical High-Risk Individuals.
PubMed 文献 · Biol Psychiatry · 2025-01-30

本研究采用多组前瞻性设计随访3年,纳入310例临床高危(CHR)个体和93名健康对照,在基线和2个月时用MATRICS共识认知成套测验评估认知。结果显示,纳入2个月认知变化后预测CHR个体未缓解的AUC从基线的0.690升至0.819(z=3.365,p<.001),但预测转化为精神病性障碍的AUC在基线与2个月认知变化间无显著差异(0.667 vs 0.666,z=0.021,p=.242)。

要点

  • CHR个体2个月认知变化预测未缓解的AUC为0.819,高于基线认知的0.690(z=3.365,p<.001)。
  • 预测转化为精神病性障碍时,基线认知AUC 0.667与2个月认知变化AUC 0.666无显著差异(z=0.021,p=.242)。
  • 言语学习和工作记忆等特定认知域对预测临床结局尤其有价值。

核心结论

  • 短期认知变化显著增强了对CHR个体未缓解的预测,但未能在基线评估之外为预测转化为精神病性障碍增加预测价值。

研究设计与样本

  • 多组前瞻性设计,随访3年,纳入310例CHR个体和93名健康对照,在基线和2个月随访时使用中文版MATRICS共识认知成套测验评估神经心理表现。

主要发现

  • 纳入2个月认知变化后预测CHR个体未缓解的AUC为0.819,基线认知为0.690(z=3.365,p<.001)。
  • 关键预测因子包括霍普金斯词语学习测验修订版(β=0.083,p=.003)、韦氏记忆量表-III空间广度(β=0.330,p<.001)和简易视空间记忆测验修订版(β=0.127,p<.001)。
  • 预测转化为精神病性障碍时,基线认知AUC为0.667,2个月认知变化AUC为0.666,两者无显著差异(z=0.021,p=.242)。

临床怎么用

  • 作者认为研究结果强调了对CHR个体进行动态认知监测的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Longitudinal changes in cognitive function may be crucial in predicting clinical outcomes in clinical high-risk (CHR) individuals. In this study, we aimed to investigate the predictive value of baseline cognitive impairment and short-term cognitive changes for nonremission and conversion to psychosis in individuals at CHR for psychosis compared with healthy control individuals (HCs). METHODS: This study used a multiple-group prospective design with a 3-year follow-up. CHR individuals and HCs were assessed at baseline and at a 2-month follow-up. Neuropsychological performance was evaluated using the Chinese version of the MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery. RESULTS: The study included 310 CHR individuals and 93 HCs. Significant improvements in predicting nonremission in CHR individuals were observed when incorporating cognitive changes over 2 months (area under the receiver operating characteristic curve [AUC] for baseline cognition, 0.690; AUC for changes, 0.819; z = 3.365, p < .001). Key predictors included the Hopkins Verbal Learning Test-Revised (β = 0.083, p = .003), Wechsler Memory Scale-III spatial span (β = 0.330, p < .001), and Brief Visuospatial Memory Test-Revised (β = 0.127, p < .001). Conversely, predicting conversion to psychosis showed no significant difference between baseline and 2-month cognitive changes (AUC for baseline cognition, 0.667; AUC for changes, 0.666; z = 0.021, p = .242). CONCLUSIONS: The findings underscore the importance of dynamic cognitive monitoring in CHR individuals. Short-term cognitive changes significantly enhanced the prediction of nonremission but did not add predictive value for conversion to psychosis beyond baseline assessments. Specific cognitive domains, such as verbal learning and working memory, were particularly valuable for predicting clinical outcomes.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhang T, Wei Y, Tang X, et al. Two-Month Cognitive Changes Enhance Prediction of Nonremission in Clinical High-Risk Individuals. Biol Psychiatry. 2025. PMID: 39892687. doi:10.1016/j.biopsych.2025.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。